vs
Side-by-side financial comparison of Relay Therapeutics, Inc. (RLAY) and Village Farms International, Inc. (VFF). Click either name above to swap in a different company.
Village Farms International, Inc. is the larger business by last-quarter revenue ($12.2M vs $7.0M, roughly 1.7× Relay Therapeutics, Inc.).
Relay Therapeutics is a clinical-stage biotechnology company focused on developing precision oncology therapies. It leverages advanced computational modeling of protein dynamics, paired with cutting-edge experimental biology, to design targeted medicines for previously intractable cancer types, serving global oncology care markets and patient populations.
Grafton Village Cheese Company is a cheesemaker in the town of Grafton in the U.S. state of Vermont. The company produces hand-crafted aged cheddar cheese.
RLAY vs VFF — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $7.0M | $12.2M |
| Net Profit | — | $2.4M |
| Gross Margin | — | — |
| Operating Margin | — | — |
| Net Margin | — | 19.9% |
| Revenue YoY | — | 31.5% |
| Net Profit YoY | — | 128.2% |
| EPS (diluted) | — | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $7.0M | $12.2M | ||
| Q3 25 | $0 | $66.7M | ||
| Q2 25 | — | $59.9M | ||
| Q1 25 | $7.7M | $77.1M | ||
| Q4 24 | $0 | — | ||
| Q3 24 | $0 | $54.9M | ||
| Q2 24 | $0 | $53.6M | ||
| Q1 24 | $10.0M | $78.1M |
| Q4 25 | — | $2.4M | ||
| Q3 25 | $-74.1M | $10.2M | ||
| Q2 25 | — | $26.5M | ||
| Q1 25 | $-77.1M | $-6.7M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-88.1M | $-820.0K | ||
| Q2 24 | $-92.2M | $-23.5M | ||
| Q1 24 | $-81.4M | $-2.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | 47.9% | ||
| Q2 25 | — | 37.3% | ||
| Q1 25 | — | 14.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 24.8% | ||
| Q2 24 | — | 25.4% | ||
| Q1 24 | — | 19.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | 23.3% | ||
| Q2 25 | — | 20.8% | ||
| Q1 25 | -1105.2% | -8.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.8% | ||
| Q2 24 | — | -43.5% | ||
| Q1 24 | -903.0% | -3.0% |
| Q4 25 | — | 19.9% | ||
| Q3 25 | — | 15.3% | ||
| Q2 25 | — | 44.2% | ||
| Q1 25 | -1003.6% | -8.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -1.5% | ||
| Q2 24 | — | -43.9% | ||
| Q1 24 | -813.3% | -3.7% |
| Q4 25 | — | $0.01 | ||
| Q3 25 | $-0.43 | $0.08 | ||
| Q2 25 | — | $0.24 | ||
| Q1 25 | $-0.46 | $-0.06 | ||
| Q4 24 | — | — | ||
| Q3 24 | $-0.63 | $-0.01 | ||
| Q2 24 | $-0.69 | $-0.21 | ||
| Q1 24 | $-0.62 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $84.0M | $81.2M |
| Total DebtLower is stronger | — | $33.7M |
| Stockholders' EquityBook value | $567.1M | $299.9M |
| Total Assets | $621.3M | $423.1M |
| Debt / EquityLower = less leverage | — | 0.11× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $84.0M | $81.2M | ||
| Q3 25 | $91.6M | $82.6M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | $93.5M | $15.1M | ||
| Q4 24 | $124.3M | — | ||
| Q3 24 | $152.4M | $28.7M | ||
| Q2 24 | $134.1M | $29.7M | ||
| Q1 24 | $152.9M | $26.7M |
| Q4 25 | — | $33.7M | ||
| Q3 25 | — | $34.6M | ||
| Q2 25 | — | $39.1M | ||
| Q1 25 | — | $39.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $43.3M | ||
| Q2 24 | — | $44.4M | ||
| Q1 24 | — | $46.1M |
| Q4 25 | $567.1M | $299.9M | ||
| Q3 25 | $607.7M | $295.4M | ||
| Q2 25 | — | $284.3M | ||
| Q1 25 | $721.1M | $248.3M | ||
| Q4 24 | $777.8M | — | ||
| Q3 24 | $838.9M | $274.4M | ||
| Q2 24 | $681.7M | $275.2M | ||
| Q1 24 | $745.8M | $296.2M |
| Q4 25 | $621.3M | $423.1M | ||
| Q3 25 | $670.0M | $418.4M | ||
| Q2 25 | — | $403.7M | ||
| Q1 25 | $799.4M | $377.1M | ||
| Q4 24 | $871.3M | — | ||
| Q3 24 | $930.1M | $417.8M | ||
| Q2 24 | $772.5M | $425.4M | ||
| Q1 24 | $841.4M | $458.4M |
| Q4 25 | — | 0.11× | ||
| Q3 25 | — | 0.12× | ||
| Q2 25 | — | 0.14× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.16× | ||
| Q2 24 | — | 0.16× | ||
| Q1 24 | — | 0.16× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-235.5M | — |
| Free Cash FlowOCF − Capex | $-235.9M | — |
| FCF MarginFCF / Revenue | -3370.0% | — |
| Capex IntensityCapex / Revenue | 5.9% | 90.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-622.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-235.5M | — | ||
| Q3 25 | $-62.1M | $24.4M | ||
| Q2 25 | — | — | ||
| Q1 25 | $-73.2M | $-6.4M | ||
| Q4 24 | $-249.1M | — | ||
| Q3 24 | $-75.1M | $4.3M | ||
| Q2 24 | $-65.8M | $5.7M | ||
| Q1 24 | $-50.3M | $-50.0K |
| Q4 25 | $-235.9M | — | ||
| Q3 25 | $-62.1M | $22.6M | ||
| Q2 25 | — | — | ||
| Q1 25 | $-73.6M | $-8.9M | ||
| Q4 24 | $-251.1M | — | ||
| Q3 24 | $-75.3M | $1.5M | ||
| Q2 24 | $-65.8M | $4.8M | ||
| Q1 24 | $-52.1M | $-1.9M |
| Q4 25 | -3370.0% | — | ||
| Q3 25 | — | 33.9% | ||
| Q2 25 | — | — | ||
| Q1 25 | -958.4% | -11.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | — | 9.0% | ||
| Q1 24 | -520.7% | -2.5% |
| Q4 25 | 5.9% | 90.8% | ||
| Q3 25 | — | 2.7% | ||
| Q2 25 | — | 4.6% | ||
| Q1 25 | 5.0% | 3.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 5.1% | ||
| Q2 24 | — | 1.6% | ||
| Q1 24 | 17.8% | 2.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | 2.39× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
RLAY
Segment breakdown not available.
VFF
| International Sales | $8.7M | 71% |
| Cannabis United States Segment | $3.4M | 27% |
